Long-Term Survival Outcome With Tyrosine Kinase Inhibitors and Surgical Intervention in Patients With Metastatic or Recurrent Gastrointestinal Stromal Tumors: A 14-Year, Single-Center Experience
Cancer Medicine - United Kingdom
doi 10.1002/cam4.1994
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2019
Authors
Publisher
Wiley